Cargando…

The Liver and Its Diseases

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	J.F.Ballantyne 1852
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937399/ https://www.ncbi.nlm.nih.gov/pubmed/37320017

Ejemplares similares

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2013)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

Unraveling Metabolic Dysfunction-Associated Fatty Liver Disease: Refining Sub-Phenotypes for Resolving Its Heterogeneity
por: Park, Jung Gil
Publicado: (2023)

Pathophysiology of cholestatic liver disease and its relevance for in vitro tests of hepatotoxicity
por: Stöber, Regina
Publicado: (2016)

PPARs and Liver Disease
por: Kondo, Yasuteru, et al.
Publicado: (2013)

Diseases of the Liver in India
Publicado: (1903)

Inflammation in Liver Diseases
por: Feng, Dechun, et al.
Publicado: (2018)

Nutrition and Liver Disease
por: Mandato, Claudia, et al.
Publicado: (2017)

Immunotherapy of Liver Diseases
por: Feng, Dechun, et al.
Publicado: (2019)

Orosomucoid in liver diseases
por: Elpek, Gulsum Ozlem
Publicado: (2021)

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
por: Jang, Heejoon, et al.
Publicado: (2023)

Pediatric liver transplantation in India: Its time has come
por: D'Cruz, Ashley L.J.
Publicado: (2011)

Fat, cancer, the gut-liver axis and rare liver diseases
por: Berenguer, Marina
Publicado: (2020)

Torque teno virus in liver diseases and after liver transplantation
por: Mrzljak, Anna, et al.
Publicado: (2020)

Advances in Alcoholic Liver Disease
por: Osna, Natalia, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Stem Cells and Liver Diseases
por: Hu, Zongyi, et al.
Publicado: (2019)

Interventional radiology for liver diseases
por: Defreyne, Luc
Publicado: (2020)

Liver resection is beneficial for patients with colorectal liver metastases and extrahepatic disease
por: Lang, Hauke
Publicado: (2020)

It’s Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging
por: Joo, Sae Kyung, et al.
Publicado: (2019)

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor
por: Gambato, Martina, et al.
Publicado: (2020)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
por: Song, Byeong Geun, et al.
Publicado: (2023)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Diagnostic and Interventional Radiology for Liver Diseases
por: Murata, Satoru, et al.
Publicado: (2015)

Complementary and Alternative Therapies for Liver Diseases
por: Guan, Yong-Song, et al.
Publicado: (2013)

Extracellular vesicles in liver disease and beyond
por: Morán, Laura, et al.
Publicado: (2018)

Glutamine, fatty liver disease and aging
por: Simón, Jorge, et al.
Publicado: (2021)

Metabolic-associated Fatty Liver Disease
por: Zheng, Ming-Hua
Publicado: (2021)

Pathophysiology of Chronic Liver Disease Development
por: Fromme, Malin, et al.
Publicado: (2022)

Editorial: The Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD) and Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: Why the American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of the Liver (EASL) Consensus Process is Not Representative
por: Fouad, Yasser Mahrous, et al.
Publicado: (2022)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Toll-Like Receptor Signaling in Liver Diseases
por: Szabo, Gyongyi, et al.
Publicado: (2010)

Biological Functions of Exosomes in the Liver in Health and Disease
por: Imani Fooladi, Abbas Ali, et al.
Publicado: (2014)

Xenon: A Solution for Anesthesia in Liver Disease?
por: Dabbagh, Ali, et al.
Publicado: (2012)

Complementary and Alternative Therapies for Liver Diseases 2014
por: Guan, Yong-Song, et al.
Publicado: (2015)

Role of Oxidative Stress in Liver Health and Disease
por: Muriel, Pablo, et al.
Publicado: (2016)

Fatty Liver Disease: Metabolic, Genetic, or Both?
por: Zoller, Heinz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oub07g2kp8mqq95e517n4phaag